Vivo Bio Tech Limited (BOM:511509)

Market Cap	600.92M -4.2%
Revenue (ttm)	514.24M +11.5%
Net Income	45.17M -35.1%
EPS	2.34 -43.8%
Shares Out	22.19M
PE Ratio	11.59
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,021
Open	27.01
Previous Close	27.18
Day's Range	26.61 - 27.49
52-Week Range	20.35 - 43.35
Beta	0.41
Analysts	n/a
Price Target	n/a
Earnings Date	May 29, 2026

About Vivo Bio Tech

Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vivo and in vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, and analytical services. It also supplies SPF lab animals; breeds and distributes rodent models; and offers custom rodent models, and stem cell products, as well as lab animal diets. In addition, the company provides regulatory and non-regulatory...

• Industry: Commercial Physical and Biological Research
• Founded: 1987
• Employees: 174
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 511509

Financial Performance

In fiscal year 2025, Vivo Bio Tech's revenue was 466.73 million, an increase of 2.69% compared to the previous year's 454.51 million. Earnings were 72.83 million, an increase of 188.27%.